BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37577386)

  • 1. A
    Shen P; Bai ZJ; Zhou L; Wang NN; Ni ZX; Sun DZ; Huang CS; Hu YY; Xiao CR; Zhou W; Zhang BL; Gao Y
    J Pharm Anal; 2023 Jul; 13(7):806-816. PubMed ID: 37577386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis.
    Bhattacharya D; Basta B; Mato JM; Craig A; Fernández-Ramos D; Lopitz-Otsoa F; Tsvirkun D; Hayardeny L; Chandar V; Schwartz RE; Villanueva A; Friedman SL
    JHEP Rep; 2021 Jun; 3(3):100237. PubMed ID: 34151243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aryl hydrocarbon receptor-mediated induction of Stearoyl-CoA desaturase 1 alters hepatic fatty acid composition in TCDD-elicited steatosis.
    Angrish MM; Jones AD; Harkema JR; Zacharewski TR
    Toxicol Sci; 2011 Dec; 124(2):299-310. PubMed ID: 21890736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
    Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
    J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms rs55710213 and rs56334587 regulate SCD1 expression by modulating HNF4A binding.
    Pan G; Cavalli M; Wadelius C
    Biochim Biophys Acta Gene Regul Mech; 2021 Aug; 1864(8):194724. PubMed ID: 34171462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase.
    Li ZZ; Berk M; McIntyre TM; Feldstein AE
    J Biol Chem; 2009 Feb; 284(9):5637-44. PubMed ID: 19119140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside Rb1 Ameliorated Bavachin-Induced Renal Fibrosis via Suppressing Bip/eIF2α/CHOP Signaling-Mediated EMT.
    Ni YH; Deng HF; Zhou L; Huang CS; Wang NN; Yue LX; Li GF; Yu HJ; Zhou W; Gao Y
    Front Pharmacol; 2022; 13():872474. PubMed ID: 35873571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of stearoyl-coenzyme A desaturase 1 ameliorates hepatic steatosis by inducing AMPK-mediated lipophagy.
    Zhou Y; Zhong L; Yu S; Shen W; Cai C; Yu H
    Aging (Albany NY); 2020 Apr; 12(8):7350-7362. PubMed ID: 32324591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oleate activates SREBP-1 signaling activity in
    Lounis MA; Bergeron KF; Burhans MS; Ntambi JM; Mounier C
    Am J Physiol Endocrinol Metab; 2017 Dec; 313(6):E710-E720. PubMed ID: 28851735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver X receptor α promotes the synthesis of monounsaturated fatty acids in goat mammary epithelial cells via the control of stearoyl-coenzyme A desaturase 1 in an SREBP-1-dependent manner.
    Yao DW; Luo J; He QY; Xu HF; Li J; Shi HB; Wang H; Chen Z; Loor JJ
    J Dairy Sci; 2016 Aug; 99(8):6391-6402. PubMed ID: 27209141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids
    Liu G; Kuang S; Cao R; Wang J; Peng Q; Sun C
    FASEB J; 2019 Sep; 33(9):10089-10103. PubMed ID: 31199678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of SCD1 activity in hepatocyte cell lines: evaluation of genomic stability and proliferation.
    de Lima Luna AC; Forti FL
    Mol Cell Biochem; 2021 Sep; 476(9):3393-3405. PubMed ID: 33954906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stearoyl-CoA desaturase 1 (SCD1) facilitates the growth and anti-ferroptosis of gastric cancer cells and predicts poor prognosis of gastric cancer.
    Wang C; Shi M; Ji J; Cai Q; Zhao Q; Jiang J; Liu J; Zhang H; Zhu Z; Zhang J
    Aging (Albany NY); 2020 Jul; 12(15):15374-15391. PubMed ID: 32726752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BTG1 ameliorates liver steatosis by decreasing stearoyl-CoA desaturase 1 (SCD1) abundance and altering hepatic lipid metabolism.
    Xiao F; Deng J; Guo Y; Niu Y; Yuan F; Yu J; Chen S; Guo F
    Sci Signal; 2016 May; 9(428):ra50. PubMed ID: 27188441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic mechanisms contribute to decrease stearoyl-CoA desaturase 1 expression in the liver of dairy cows after prolonged feeding of high-concentrate diet.
    Xu TL; Seyfert HM; Shen XZ
    J Dairy Sci; 2018 Mar; 101(3):2506-2518. PubMed ID: 29274956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional control of the stearoyl-CoA desaturase-1 gene by polyunsaturated fatty acids.
    Landschulz KT; Jump DB; MacDougald OA; Lane MD
    Biochem Biophys Res Commun; 1994 Apr; 200(2):763-8. PubMed ID: 7910016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase.
    Liu J; Cinar R; Xiong K; Godlewski G; Jourdan T; Lin Y; Ntambi JM; Kunos G
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18832-7. PubMed ID: 24191036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biochemical relevance of monounsaturated fatty acid metabolism targeting strategy for cancer stem cell elimination in colon cancer.
    Choi S; Yoo YJ; Kim H; Lee H; Chung H; Nam MH; Moon JY; Lee HS; Yoon S; Kim WY
    Biochem Biophys Res Commun; 2019 Oct; 519(1):100-105. PubMed ID: 31481234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
    Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
    Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1.
    Jiang G; Li Z; Liu F; Ellsworth K; Dallas-Yang Q; Wu M; Ronan J; Esau C; Murphy C; Szalkowski D; Bergeron R; Doebber T; Zhang BB
    J Clin Invest; 2005 Apr; 115(4):1030-8. PubMed ID: 15761499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.